Exelixis
EXEL
#1720
Rank
S$16.15 B
Marketcap
S$64.27
Share price
-0.40%
Change (1 day)
16.66%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company